Last $33.84 USD
Change Today -1.72 / -4.84%
Volume 1.4M
ACOR On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for acorda therapeutics inc (ACOR)

Year over year, Acorda Therapeutics, Inc. has been able to grow revenues from $336.4M USD to $401.5M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 54.85% to 48.46%. This was a driver that led to a bottom line growth from $16.4M USD to $17.7M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Reclassified
Dec 31
2012
Dec 31
2013
Dec 31
2014
Press
Release
4 Year
Trend
Revenues292.2305.8336.4401.5
TOTAL REVENUES292.2305.8336.4401.5
Cost of Goods Sold53.657.666.680.6
GROSS PROFIT238.7248.2269.8320.9
Selling General & Admin Expenses, Total147.2168.0184.5194.6
R&D Expenses42.153.953.973.5
OTHER OPERATING EXPENSES, TOTAL189.3221.9238.4268.0
OPERATING INCOME49.426.331.452.8
Interest Expense-3.6-1.9-2.2--
Interest and Investment Income0.60.60.7--
NET INTEREST EXPENSE-3.0-1.3-1.5--
Other Non-Operating Income (Expenses)0.00.0---8.4
EBT, EXCLUDING UNUSUAL ITEMS46.324.929.944.4
Merger & Restructuring Charges-----1.0-7.2
Other Unusual Items, Total-14.3-0.7---9.2
Legal Settlements-14.3------
Other Unusual Items-------2.2
EBT, INCLUDING UNUSUAL ITEMS32.024.328.928.0
Income Tax Expense1.4-130.712.410.3
Earnings from Continuing Operations30.6155.016.417.7
NET INCOME30.6155.016.417.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS30.6155.016.417.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS30.6155.016.417.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $33.84 USD -1.72

ACOR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ACADIA Pharmaceuticals Inc $37.97 USD +0.19
Biogen Idec Inc $409.59 USD -0.51
Depomed Inc $21.95 USD -0.65
Durect Corp $1.05 USD -0.02
Isis Pharmaceuticals Inc $68.56 USD +1.23
View Industry Companies
 

Industry Analysis

ACOR

Industry Average

Valuation ACOR Industry Range
Price/Earnings 81.5x
Price/Sales 3.5x
Price/Book 2.6x
Price/Cash Flow 80.3x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.